Software Updates for Insulin Pumps - Upgrade your Pump Remotely

The software update for Control-IQ technology is now available for in‑warranty t:slim X2 insulin pump users.

Control-IQ™ technology on the t:slim X2™ insulin pump is designed to help increase time in range (70-180 mg/dL)* using Dexcom G6 continuous glucose monitoring (CGM)^† values to predict glucose levels 30 minutes ahead and adjust insulin accordingly. A prescription and online training are required in order to receive the unique Update ID code needed to complete your software update.

What is an Update ID code?

What is the update process?

t:slim X2 Insulin Pump with Control-IQ Technology

What is an Update ID code?

Your unique Update ID code is required to complete the software update on your t:slim X2 insulin pump, and is delivered to you via email once you have successfully completed online training. To start the process and receive your Update ID code, you must first request your software update through the t:connect® portal.

I have my Update ID code

If we have a verified prescription, you've completed your online training, and you've received your Update ID code email from Tandem, you’re ready to update your pump.

Update Your Pump

I need an Update ID code

If you haven’t requested a prescription or completed online training, visit the portal to start the process. Update ID codes are delivered following completion of online training.

start the process

Check Your Progress

If you’ve already requested your update, you can check your progress by logging back into the t:connect portal. The prescription process can take a few days, depending on healthcare provider availability. Please allow up to two weeks before calling Customer Technical Support for an update, and help us keep the phone lines open for customers who may be experiencing an interruption in insulin delivery.

What is the update process?

You can initiate your request for a software update in the easy-to-use t:connect portal. Below are the steps in the process, and general guidelines for how long each can take. You can always log into the t:connect portal to review your latest status.

To submit your request for Control-IQ technology, log in to the t:connect portal, select “My Devices” at the top of the page, and select your software update. Your submission will trigger an automated prescription request to your healthcare provider (HCP)
Your healthcare provider then signs and returns your prescription at their discretion (Can take 2-14 days, depending on HCP availability)
Once we receive, review, and process the signed prescription, you will receive notice of your training via email (Can take 1-7 days)
Following completion of your training, we will send you another email with your software Update ID code and instructions on how to install Control-IQ technology on your pump (Can take up to 1 day)

For more information on the update process, visit Customer Support Update page.

Notes Icon

Responsible Use of Control-IQ Technology

Even with advanced systems such as the t:slim X2 insulin pump with Control-IQ technology, you are still responsible for actively managing your diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires your accurate input of information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless you use all system components, including your CGM, infusion sets and pump cartridges, as instructed. Importantly, the system cannot adjust your insulin dosing if the pump is not receiving CGM readings. Since there are situations and emergencies that the system may not be capable of identifying or addressing, always pay attention to your symptoms and treat according to your healthcare provider’s recommendations.

Important Safety Information

RX ONLY. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump and Control-IQ technology are indicated for use with NovoLog or Humalog U-100 insulin.

t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The t:slim X2 pump is indicated for use in individuals six years of age and greater. Control-IQ technology: Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater.

WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump and Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment. Visit www.tandemdiabetes.com/safetyinfo for additional important safety information.

Cookie Policy